Dr. Timothy Smith and Dr. Lindsay Weitzel compare and contrast three oral gepants, an IV monoclonal antibody, two combination therapies, and an anti-inflammatory agent, all expected to be available for the treatment of migraine very soon. For more information visit www.headaches.org